June 16, 2021 -- Thermo Fisher Scientific is accepting clinical research project submissions in immuno-oncology for its Oncomine Clinical Research Grant program.
The program funds molecular profiling studies that focus on the effect of immune-based treatments for cancer patients. Chosen research teams will be awarded with up to $200,000 in reagents and general funding.
Since its launch in 2020, the grant has been awarded to eight projects worldwide, supporting research in areas including fusion genes detection in solid cancer and hemato-oncology.
Proposals must be submitted to the program by July 16.